Eva Kim, MD
Ophthalmology · Denver, CONPI 1457401259
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $69,520 of the $94,961 with a category attached, or 73.2%. 33 manufacturers reported payments, led by Alcon at 53.4% of the total. Among ophthalmology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 378 payments — averaging $251.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$51K
- Rxsight Inc$27K
- Alcon Research LLC$9K
- Glaukos Corporation$5K
- Bausch & Lomb Americas Inc.$982
- AbbVie$588
- plus $2K from 27 others
What the payments were for
- Consulting fees$69,52073%
- Speaking & faculty fees$4,9515%
- Travel & lodging$5,3746%
- Food & beverage$15,04616%
- Education$170%
- Gifts$530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 221 | $50,665 |
| Rxsight Inc | 28 | $27,247 |
| Alcon Research LLC | 13 | $8,731 |
| Glaukos Corporation | 24 | $4,591 |
| Bausch & Lomb Americas Inc. | 10 | $982 |
| AbbVie(2 entities) | 17 | $588 |
| Biotissue Holdings Inc. | 12 | $448 |
| Sun Pharmaceutical Industries Inc. | 4 | $201 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $177 |
| Amgen(2 entities) | 2 | $165 |
| Dompe US, Inc. | 3 | $162 |
| Carl Zeiss Meditec, Inc. | 2 | $139 |
| Novartis | 5 | $128 |
| Sight Sciences, Inc. | 2 | $127 |
| NEW World Medical,inc. | 1 | $87 |
| Ocular Therapeutix, Inc. | 4 | $60 |
| Thea Pharma Inc. | 3 | $51 |
| Akorn, Inc. | 3 | $47 |
| Staar Surgical Company | 3 | $47 |
| Mallinckrodt Hospital Products Inc. | 3 | $45 |
| Akorn Operating Company LLC | 2 | $31 |
| Lumibird Medical Inc. | 2 | $28 |
| Shire North American Group Inc | 1 | $24 |
| Tarsus Pharmaceuticals, Inc. | 1 | $23 |
| Kala Pharmaceuticals, Inc. | 1 | $22 |
| Aerie Pharmaceuticals, Inc. | 1 | $22 |
| Coopervision Inc. | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Omeros Corporation | 1 | $19 |
| Eyepoint US, Inc. | 1 | $18 |
| Travere Therapeutics, Inc. | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
| Johnson & Johnson Vision Care, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$26,771
- RXSIGHT INJECTOR CARTRIDGE$26,771
- RXSIGHT INJECTOR HANDPIECE$26,771
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$26,771
- LIGHT ADJUSTABLE LENS (LAL)$26,544
- Clareon$17,562
- AcrySof IQ PanOptix UV IOL$15,094
- AcrySof IQ VIVITY$11,540
- LenSx$11,478
- Unity$5,047
- Clareon PanOptix Pro$4,925
- Wavelight Refractive Suite$4,344
- NGENUITY$1,950
- Travoprost Intraocular Implant - iDose$1,450
- KXL System$1,088
- ILUX$1,050
- Centurion$700
- iDoseTR$568
- ORA System VerifEye$456
- MIEBO$425
How this compares
$94,961 in reported general payments places this provider in the 95th percentile of 262 ophthalmology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 356 | $19,377 |
| Diclofenac Sodium | 435 | $5,055 |
| Ofloxacin | 345 | $3,734 |
| Latanoprost | 58 | $528 |
| Timolol Maleate | 25 | $404 |
| Dorzolamide Hcl | 18 | $99 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $92 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Denver
- Mark DaceyDenver$370K
- Cristos IfantidesDenver$343K
- Jack ZamoraDenver$172K
- Michael JansenDenver$95K
- Kingsley OkaforDenver$62K
- Curtis HagedornDenver$25K
- Michael SolomonDenver$12K
- Peter HovlandDenver$10K
- Matthew KrugerDenver$8K
- Stuart LewisDenver$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.